SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-19-023581
Filing Date
2019-09-13
Accepted
2019-09-13 19:18:17
Documents
1
Period of Report
2019-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 6705
  Complete submission text file 0000899243-19-023581.txt   8242
Mailing Address 401 TERRY AVENUE NORTH SEATTLE WA 98109
Business Address 401 TERRY AVENUE NORTH SEATTLE WA 98109 206-732-2133
Neoleukin Therapeutics, Inc. (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
DRACHMAN JONATHAN G (Reporting) CIK: 0001588467 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36327 | Film No.: 191093482